Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Users | 3 | 2022 | 21 | 1.160 |
Why?
|
| Hepatitis C | 3 | 2022 | 172 | 1.000 |
Why?
|
| Colorectal Neoplasms | 4 | 2024 | 981 | 0.860 |
Why?
|
| Adenoma | 2 | 2024 | 246 | 0.740 |
Why?
|
| Computer Simulation | 4 | 2024 | 1097 | 0.700 |
Why?
|
| Colonoscopy | 3 | 2024 | 279 | 0.550 |
Why?
|
| HIV Infections | 6 | 2022 | 840 | 0.530 |
Why?
|
| Early Detection of Cancer | 4 | 2024 | 416 | 0.490 |
Why?
|
| Models, Theoretical | 3 | 2022 | 491 | 0.430 |
Why?
|
| Opioid-Related Disorders | 2 | 2024 | 189 | 0.380 |
Why?
|
| Pre-Exposure Prophylaxis | 3 | 2021 | 147 | 0.330 |
Why?
|
| Chicago | 6 | 2022 | 1427 | 0.310 |
Why?
|
| Referral and Consultation | 2 | 2021 | 341 | 0.300 |
Why?
|
| Neoplasms | 2 | 2018 | 3041 | 0.280 |
Why?
|
| Population Growth | 1 | 2005 | 11 | 0.260 |
Why?
|
| Fractals | 1 | 2005 | 42 | 0.260 |
Why?
|
| Emigration and Immigration | 1 | 2005 | 48 | 0.260 |
Why?
|
| Substance Abuse, Intravenous | 2 | 2024 | 59 | 0.250 |
Why?
|
| Bayes Theorem | 2 | 2024 | 370 | 0.250 |
Why?
|
| Occult Blood | 1 | 2024 | 17 | 0.240 |
Why?
|
| Naloxone | 1 | 2024 | 67 | 0.240 |
Why?
|
| Incidence | 4 | 2022 | 1595 | 0.240 |
Why?
|
| Cost-Benefit Analysis | 2 | 2024 | 461 | 0.230 |
Why?
|
| Opiate Substitution Treatment | 1 | 2024 | 40 | 0.230 |
Why?
|
| Methadone | 1 | 2024 | 46 | 0.230 |
Why?
|
| Reproduction | 1 | 2005 | 199 | 0.230 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2024 | 142 | 0.230 |
Why?
|
| Risk-Taking | 2 | 2022 | 155 | 0.220 |
Why?
|
| Homosexuality, Male | 3 | 2022 | 299 | 0.220 |
Why?
|
| Narcotic Antagonists | 1 | 2024 | 160 | 0.220 |
Why?
|
| Humans | 24 | 2024 | 89357 | 0.210 |
Why?
|
| Hepatitis B | 1 | 2023 | 76 | 0.210 |
Why?
|
| Policy | 1 | 2022 | 35 | 0.200 |
Why?
|
| Virus Replication | 1 | 2023 | 324 | 0.200 |
Why?
|
| Hepacivirus | 2 | 2022 | 130 | 0.200 |
Why?
|
| Sexual and Gender Minorities | 2 | 2022 | 208 | 0.200 |
Why?
|
| Health Information Exchange | 1 | 2021 | 12 | 0.200 |
Why?
|
| Hand Disinfection | 1 | 2021 | 17 | 0.200 |
Why?
|
| Systems Analysis | 1 | 2021 | 17 | 0.200 |
Why?
|
| Viremia | 1 | 2021 | 49 | 0.200 |
Why?
|
| Workflow | 2 | 2018 | 80 | 0.190 |
Why?
|
| Community Networks | 1 | 2021 | 30 | 0.190 |
Why?
|
| Masks | 1 | 2021 | 29 | 0.190 |
Why?
|
| Social Class | 1 | 2022 | 136 | 0.190 |
Why?
|
| Hepatitis C, Chronic | 1 | 2022 | 91 | 0.190 |
Why?
|
| Young Adult | 6 | 2022 | 6312 | 0.190 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 428 | 0.180 |
Why?
|
| Crime | 1 | 2020 | 37 | 0.180 |
Why?
|
| Adolescent | 6 | 2022 | 9263 | 0.180 |
Why?
|
| Criminals | 1 | 2020 | 33 | 0.180 |
Why?
|
| Viral Hepatitis Vaccines | 1 | 2019 | 5 | 0.170 |
Why?
|
| Disease Transmission, Infectious | 1 | 2019 | 58 | 0.160 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 159 | 0.160 |
Why?
|
| Residence Characteristics | 1 | 2020 | 202 | 0.160 |
Why?
|
| Transgender Persons | 1 | 2020 | 107 | 0.160 |
Why?
|
| Models, Biological | 1 | 2005 | 1765 | 0.160 |
Why?
|
| Algorithms | 2 | 2024 | 1877 | 0.150 |
Why?
|
| Adult | 9 | 2024 | 26607 | 0.150 |
Why?
|
| Patient Compliance | 1 | 2019 | 231 | 0.150 |
Why?
|
| Smoking Cessation | 1 | 2019 | 253 | 0.140 |
Why?
|
| Machine Learning | 1 | 2018 | 258 | 0.130 |
Why?
|
| Illinois | 3 | 2024 | 480 | 0.130 |
Why?
|
| Male | 10 | 2024 | 42411 | 0.130 |
Why?
|
| Calibration | 2 | 2024 | 104 | 0.110 |
Why?
|
| Middle Aged | 5 | 2024 | 25974 | 0.100 |
Why?
|
| Female | 6 | 2024 | 46202 | 0.090 |
Why?
|
| Mass Screening | 2 | 2024 | 636 | 0.080 |
Why?
|
| Pandemics | 2 | 2023 | 773 | 0.070 |
Why?
|
| Hematologic Tests | 1 | 2024 | 15 | 0.060 |
Why?
|
| Needle Sharing | 1 | 2024 | 15 | 0.060 |
Why?
|
| Aged | 4 | 2024 | 19165 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2021 | 2872 | 0.060 |
Why?
|
| Monte Carlo Method | 1 | 2024 | 186 | 0.060 |
Why?
|
| Drug Overdose | 1 | 2024 | 74 | 0.060 |
Why?
|
| Hepatitis B virus | 1 | 2023 | 44 | 0.060 |
Why?
|
| Virion | 1 | 2023 | 59 | 0.050 |
Why?
|
| Texas | 1 | 2022 | 113 | 0.050 |
Why?
|
| HIV | 1 | 2022 | 48 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2023 | 262 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 2624 | 0.050 |
Why?
|
| Infectious Disease Medicine | 1 | 2021 | 7 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 50 | 0.050 |
Why?
|
| California | 1 | 2021 | 144 | 0.050 |
Why?
|
| Uncertainty | 1 | 2021 | 74 | 0.050 |
Why?
|
| San Francisco | 1 | 2020 | 24 | 0.050 |
Why?
|
| Computational Biology | 1 | 2024 | 543 | 0.050 |
Why?
|
| Geography | 1 | 2021 | 227 | 0.050 |
Why?
|
| Sexual Partners | 1 | 2021 | 101 | 0.050 |
Why?
|
| Probability | 1 | 2021 | 353 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2021 | 371 | 0.050 |
Why?
|
| Kinetics | 1 | 2023 | 1528 | 0.050 |
Why?
|
| United States | 2 | 2024 | 6989 | 0.040 |
Why?
|
| Public Health | 1 | 2021 | 138 | 0.040 |
Why?
|
| Health Behavior | 1 | 2021 | 185 | 0.040 |
Why?
|
| Poverty | 1 | 2021 | 180 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2024 | 2015 | 0.040 |
Why?
|
| Health Policy | 1 | 2021 | 185 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 444 | 0.040 |
Why?
|
| Vaccine Potency | 1 | 2019 | 1 | 0.040 |
Why?
|
| Forecasting | 1 | 2020 | 306 | 0.040 |
Why?
|
| Internet | 1 | 2021 | 319 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 988 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2022 | 478 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 260 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 588 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 1066 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2019 | 235 | 0.040 |
Why?
|
| Vaccination | 1 | 2019 | 274 | 0.040 |
Why?
|
| Logistic Models | 1 | 2020 | 1213 | 0.030 |
Why?
|
| Hospitalization | 1 | 2022 | 877 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 1549 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1714 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2019 | 576 | 0.030 |
Why?
|
| Decision Making | 1 | 2021 | 667 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2019 | 347 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1243 | 0.030 |
Why?
|
| Animals | 2 | 2023 | 27371 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6811 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 11761 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 8241 | 0.020 |
Why?
|